Chetan Bettegowda

Johns Hopkins University

Full Professor(heuristic)

Glioma Diagnosis and Treatment · Genetics

Compare more Genetics professors.

h-index69
i10-index247
Publications736
Citations32,851

Grants

10 total · 6 active

NIH #R01FD007271

Phase IIA Trial of Dichloroacetate for Glioblastoma Multiforme, IND137007, 09172019

Expiring Soon
Amount
$600K–$700K
Period
2021-09-01 → 2026-08-31
PIs
3

Awarded at UNIVERSITY OF FLORIDA

NIH #UE5NS065729

Research Education Program for Residents and Fellows in Neurology

Active
Amount
$300K–$400K
Period
2009-03-01 → 2030-06-30
PIs
2

NIH #U01CA230691

Multi-analyte Approach for Earlier Detection of Cancers in Non Plasma Biofluids

Active
Amount
$900K–$1000K
Period
2018-09-19 → 2028-08-31
PIs
3

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

10 total · 6 active

NIH #R01FD007271

Phase IIA Trial of Dichloroacetate for Glioblastoma Multiforme, IND137007, 09172019

Expiring Soon
Amount
$600K–$700K
Period
2021-09-01 → 2026-08-31
PIs
3

Awarded at UNIVERSITY OF FLORIDA

NIH #UE5NS065729

Research Education Program for Residents and Fellows in Neurology

Active
Amount
$300K–$400K
Period
2009-03-01 → 2030-06-30
PIs
2

NIH #U01CA230691

Multi-analyte Approach for Earlier Detection of Cancers in Non Plasma Biofluids

Active
Amount
$900K–$1000K
Period
2018-09-19 → 2028-08-31
PIs
3

NIH #R01CA276221

Integrating circulating tumor DNA assay and protein-based MRI to accurately monitor glioma therapy

Active
Amount
$600K–$700K
Period
2023-07-01 → 2028-06-30
PIs
2

NIH #U01CA271867

Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablation

Active
Amount
$1M–$2M
Period
2022-09-22 → 2027-08-31
PIs
6

Awarded at CASE WESTERN RESERVE UNIVERSITY

NIH #R42NS135834

Multi-omic CSF Assay for the Diagnosis of Brain Cancers

Active
Amount
$800K–$900K
Period
2024-07-01 → 2026-12-31
PIs
2

Awarded at BELAY DIAGNOSTICS, LLC

NIH #R21TR004059

Cell-free DNA-Based Analysis for Diagnosis, Monitoring and Optimization of Therapy for Patients with Primary Central Nervous System Lymphomas

Amount
$200K–$300K
Period
2022-09-15 → 2025-07-31
PIs
2

NIH #R37CA230400

Interrogating malignant gliomas using released tumor DNA in cerebrospinal fluid

Amount
$300K–$400K
Period
2018-07-01 → 2023-06-30
PIs
1

NIH #R21NS113016

MRgFUS-enabled non-invasive interrogation of malignant glioma via circulating tumor DNA

Amount
$400K–$500K
Period
2019-07-15 → 2023-06-30
PIs
2

NIH #R21CA208723

(PQ 6) Exploiting Frequent Alterations in the PRC2 Complex to Distinguish Benign Neurofibromas from Malignant Peripheral Nerve Sheath Tumors

Amount
$200K–$300K
Period
2016-09-01 → 2018-08-31
PIs
1

Recent Public Signals

  1. New paper: Sa1082 NEO-SQUAMOUS EPITHELIUM IS NOT ALWAYS “NORMAL”: METHYLATION OF VIM AND CCNA1 PREDICTS RECURRENCE AFTER INITIALLY SUCCESSFUL ERADICATION OF DYSPLASTIC BARRETT’S ESOPHAGUS (Gastrointestinal Endoscopy)2026-05-01
  2. New NIH award: Multi-omic CSF Assay for the Diagnosis of Brain Cancers2024-07-01
  3. New NIH award: Integrating circulating tumor DNA assay and protein-based MRI to accurately monitor glioma therapy2023-07-01

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-08-29

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0001-9991-7123

Professor Insights

Career Trajectory